133 related articles for article (PubMed ID: 38651688)
21. Not a Straight Line-Patients' Experiences of Prostate Cancer and Their Journey Through the Healthcare System.
Schildmeijer K; Frykholm O; Kneck Å; Ekstedt M
Cancer Nurs; 2019; 42(1):E36-E43. PubMed ID: 29334523
[TBL] [Abstract][Full Text] [Related]
22. A Norwegian perspective on the Swedish national guidelines on prostate cancer for non-metastatic disease.
Axcrona K; Löffeler S
Scand J Urol; 2022 Aug; 56(4):274-276. PubMed ID: 35811479
[No Abstract] [Full Text] [Related]
23. Critical review: is watchful waiting a viable management option for older men with prostate cancer?
Bailey DE; Wallace M
Am J Mens Health; 2007 Mar; 1(1):18-28. PubMed ID: 19482780
[TBL] [Abstract][Full Text] [Related]
24. Men's experiences of receiving a prostate cancer diagnosis after opportunistic screening-A qualitative descriptive secondary analysis.
Gellerstedt L; Langius-Eklöf A; Kelmendi N; Sundberg K; Craftman ÅG
Health Expect; 2022 Oct; 25(5):2485-2491. PubMed ID: 35898187
[TBL] [Abstract][Full Text] [Related]
25. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
[TBL] [Abstract][Full Text] [Related]
26. Prostate cancer screening.
Cook ED; Nelson AC
Curr Oncol Rep; 2011 Feb; 13(1):57-62. PubMed ID: 20981510
[TBL] [Abstract][Full Text] [Related]
27. Population-Based Assessment of Determining Treatments for Prostate Cancer.
Chamie K; Williams SB; Hu JC
JAMA Oncol; 2015 Apr; 1(1):60-7. PubMed ID: 26182305
[TBL] [Abstract][Full Text] [Related]
28. Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of Sweden.
Stattin P; Holmberg E; Bratt O; Adolfsson J; Johansson JE; Hugosson J;
J Urol; 2008 Dec; 180(6):2423-9; discussion 2429-30. PubMed ID: 18930283
[TBL] [Abstract][Full Text] [Related]
29. Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
Lane A; Metcalfe C; Young GJ; Peters TJ; Blazeby J; Avery KN; Dedman D; Down L; Mason MD; Neal DE; Hamdy FC; Donovan JL;
BJU Int; 2016 Dec; 118(6):869-879. PubMed ID: 27415448
[TBL] [Abstract][Full Text] [Related]
30. Men's perception of information and descriptions of emotional strain in the diagnostic phase of prostate cancer-a qualitative individual interview study.
Juul Søndergaard ME; Lode K; Kjosavik SR; Husebø SE
Scand J Prim Health Care; 2021 Dec; 39(4):476-485. PubMed ID: 34806534
[TBL] [Abstract][Full Text] [Related]
31. Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: a population-based study from the National Prostate Cancer Register of Sweden.
Bratt O; Berglund A; Adolfsson J; Johansson JE; Törnblom M; Stattin P;
Scand J Urol Nephrol; 2010 Dec; 44(6):384-90. PubMed ID: 20624113
[TBL] [Abstract][Full Text] [Related]
32. Sexual side effects and prostate cancer treatment decisions: patient information needs and preferences.
Knight SJ; Latini DM
Cancer J; 2009; 15(1):41-4. PubMed ID: 19197172
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of self-estimation of disuric disorders gauged IPSS scale and qualities of lives QoL with self-estimation of sexual life gauged by IIEF-5 scale].
Lipczyński W; Dobrowolska-Glazar B; Dobrowolski ZF
Przegl Lek; 2012; 69(6):247-52. PubMed ID: 23094437
[TBL] [Abstract][Full Text] [Related]
34. Barriers to sexual recovery in men with prostate, bladder and colorectal cancer.
Zhu A; Wittmann D
Urol Oncol; 2022 Sep; 40(9):395-402. PubMed ID: 32868190
[TBL] [Abstract][Full Text] [Related]
35. Is 'watchful waiting' a real choice for men with prostate cancer? A qualitative study.
Chapple A; Ziebland S; Herxheimer A; McPherson A; Shepperd S; Miller R
BJU Int; 2002 Aug; 90(3):257-64. PubMed ID: 12133062
[TBL] [Abstract][Full Text] [Related]
36. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
[TBL] [Abstract][Full Text] [Related]
37. Prospective Quality of Life in Men Choosing Active Surveillance Compared to Those Biopsied but not Diagnosed with Prostate Cancer.
Pham KN; Cullen J; Hurwitz LM; Wolff EM; Levie KE; Odem-Davis K; Banerji JS; Rosner IL; Brand TC; L'Esperance JO; Sterbis JR; Porter CR
J Urol; 2016 Aug; 196(2):392-8. PubMed ID: 26976206
[TBL] [Abstract][Full Text] [Related]
38. Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis.
Carlsson SV; de Carvalho TM; Roobol MJ; Hugosson J; Auvinen A; Kwiatkowski M; Villers A; Zappa M; Nelen V; Páez A; Eastham JA; Lilja H; de Koning HJ; Vickers AJ; Heijnsdijk EA
Cancer; 2016 Nov; 122(21):3386-3393. PubMed ID: 27459245
[TBL] [Abstract][Full Text] [Related]
39. Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.
Bratt O; Folkvaljon Y; Hjälm Eriksson M; Akre O; Carlsson S; Drevin L; Franck Lissbrant I; Makarov D; Loeb S; Stattin P
Eur Urol; 2015 Jul; 68(1):53-8. PubMed ID: 25813688
[TBL] [Abstract][Full Text] [Related]
40. Synthetic sling or artificial urinary sphincter for men with urodynamic stress incontinence after prostate surgery: the MASTER non-inferiority RCT.
Constable L; Abrams P; Cooper D; Kilonzo M; Cotterill N; Harding C; Drake MJ; Pardoe MN; McDonald A; Smith R; Norrie J; McCormack K; Ramsay C; Uren A; Mundy T; Glazener C; MacLennan G
Health Technol Assess; 2022 Aug; 26(36):1-152. PubMed ID: 35972773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
